Scientists seek hydrogen fuel for various programs. (News from the Lab...
February 24, 2003
|
NPS, Enzon plan to merge in deal valued at $1.6b.(NPS Pharmaceuticals ...
February 24, 2003
|
FDA announces new manufacturing initiatives.(United States Food and Dr...
February 24, 2003
|
SomaLogic raises $19.5m for proteomics products.(biotechnology industr...
February 24, 2003
|
Biogen's Amevive rejected in Europe.(licensing approval denied)(Brief ...
February 24, 2003
|
British government fostering U.S. development.(by encouraging partners...
February 24, 2003
|
BattellePharma raises $22m for inhalation program.(pharmaceutical indu...
February 24, 2003
|
Sunesis, Merck enter alliance for Alzheimer's.(Sunesis Pharmaceuticals...
February 24, 2003
|
Dolly the cloned sheep opened research doors.(July 5, 1996 - Feb. 14, ...
February 24, 2003
|
$10m private placement gives Onyx added funding.(Onyx Pharmaceuticals ...
February 24, 2003
|
Cost-cutting measures taken at Introgen.(Introgen Therapeutics Inc.)(B...
February 24, 2003
|
SangStat, Abgenix drop GVHD drug on poor data.(SangStat Medical Corp. ...
February 24, 2003
|
La Jolla's stock tumbles after failure of drug.(La Jolla Pharmaceutica...
February 24, 2003
|
Vertex, GSK present preliminary results from trials.(Vertex Pharmaceut...
February 24, 2003
|
GSK's decision to limit sales rankles some.(GlaxoSmithKline PLC)(Brief...
February 24, 2003
|
Neose secures $17m privately for internal programs.(Neose Technologies...
February 24, 2003
|
Cephalon plans $161m purchase of SIRTeX.(Cephalon Australia Proprietar...
February 17, 2003
|
Epimmune plans acquisition of Anosys.(Brief Article)
February 17, 2003
|
RAC says stopping trials unwarranted.(Brief Article)
February 17, 2003
|
Albany Molecular expands via Lilly deal.(Albany Molecular Research Inc...
February 17, 2003
|
Johnson & Johnson buying Scios in $2.4 billion cash deal.
February 17, 2003
|
Misfolded amyloid proteins threaten many diseases. (News: From the Lab...
February 17, 2003
|
ImClone offers drug in limited access program.(Brief Article)
February 17, 2003
|
FDA allowing Biogen broader label.(Brief Article)
February 17, 2003
|
IntraBiotics pinning hopes on iseganan study.(Brief Article)
February 17, 2003
|
OSI buying Cell Pathways for $32m in stock.(OSI Pharmaceuticals Inc.)(...
February 17, 2003
|
Gilead reports positive results from studies.(Brief Article)
February 17, 2003
|
Accelrys, Confirmant to produce protein database.(Brief Article)
February 17, 2003
|
Ribozyme raises $48m, focuses on RNAi research.(Brief Article)
February 17, 2003
|
Budget calls for funding for terror threats.(Brief Article)
February 17, 2003
|
Cell Genesys Inc. to focus on cancer, cuts programs.(Brief Article)
February 10, 2003
|
Invitrogen buys rights from Vertex unit for $95M.(Brief Article)
February 10, 2003
|
Rigel Pharmaceuticals Inc. reduces staff again; expects phase II this ...
February 10, 2003
|
Abgenix Inc. , Chugai Pharmaceutical Company Ltd. align in antibody th...
February 10, 2003
|
Bush budget allocates $6B to vaccine research.(Brief Article)
February 10, 2003
|
Biogen Inc. to pay Schering $55M to end dispute.(Brief Article)
February 10, 2003
|
NeoPharm to hasten LEP (liposomal encapsulated paclitaxel) drug develo...
February 10, 2003
|
Texas Biotechnology regains rights from ICOS Corp.(Brief Article)
February 10, 2003
|
McClellan to speed drug approval process.(Brief Article)
February 10, 2003
|
Ecopia BioSciences Inc. drills deep to reveal Antitumor enediynes.(Bri...
February 10, 2003
|
Biogen Inc. receives approval for Amevive, aligns with IDEC.(Brief Art...
February 10, 2003
|
TransTech raises $24.5M through two rounds.(Brief Article)
February 10, 2003
|
MaxCyte, Northern Therapeutics enter deal.(Brief Article)
February 10, 2003
|
BioMimetic Pharmaceuticals Inc. licenses PDGF [recombinant human plate...
February 10, 2003
|
BioMarin Pharmaceutical Inc. files for public offering.(Brief Article)
February 10, 2003
|
Ingelheim starts Phase III trials of tipranavir.(Boehringer Ingelheim)...
February 10, 2003
|
Genentech, Serono Raptiva deal widened.(Brief Article)
February 10, 2003
|
Schering AG gets rights to ILEX Oncology Inc.'s Campath.(Brief Article...
February 10, 2003
|
Bipartisan group supports therapeutic cloning.(Brief Article)
February 10, 2003
|
Icogen Corp. receives $1M SBIR award for research.(Brief Article)
February 10, 2003
|
Corixa Corp., Japan Tobacco rework agreement.(Brief Article)
February 10, 2003
|
PDL [Protein Design Labs Inc.] enters Eos Biotechnology Inc. buyout de...
February 10, 2003
|
Selling to King, Elan continues divestiture.(Elan Corporation PLC and ...
February 03, 2003
|
Biotech reps square off with feds.(Brief Article)
February 03, 2003
|
Corixa, GSK change terms of vaccine agreement.(Corixa Corp. and GlaxoS...
February 03, 2003
|
Affymetrix signs deal with Roche Diagnostics.(Affymetrix Inc. and Roch...
February 03, 2003
|
Lipid Sciences cuts work force, refocuses.(Lipid Sciences Inc.)(Brief ...
February 03, 2003
|
AtheroGenics raises $45m with 7.2m-share offering.(AtheroGenics Inc.)(...
February 03, 2003
|
FDA response letter good for BioMarin, Genzyme.(BioMarin Pharmaceutica...
February 03, 2003
|
Genaera stops enrolling in Phase llb study.(Genaera Corp.)(Brief Artic...
February 03, 2003
|
Genome Therapeutics, MerLion collaborate.(Genome Therapeutics Corp. an...
February 03, 2003
|
GTx partners VSV technology with Wyeth.(GTx Inc., Wyeth-Ayerst Laborat...
February 03, 2003
|
NaPro buys Pangene's genomics business.(NaPro BioTherapeutics Inc. and...
February 03, 2003
|
Perlegen closes notable round in tough market.(Perlegen Sciences Inc.)...
February 03, 2003
|
Onyx stops one Phase III, restructures for another.(Onyx Pharmaceutica...
February 03, 2003
|
Nastech regains rights to ED product.(Nastech Pharmaceutical Company I...
February 03, 2003
|
BIO hires VP for science, regulatory department.(Biotechnology Industr...
February 03, 2003
|
Pestka looks to improve utility of interferons.(Pestka Biomedical Labo...
February 03, 2003
|
Celator brings in $6.8m with early research efforts.(Celator Technolog...
February 03, 2003
|
GSK, ImmunoGen ending TAP cancer drug deal.(GlaxoSmithKline PLC and Im...
February 03, 2003
|
Breast cancer gene discovery hints at tests, vaccines. (News from the ...
February 03, 2003
|
FDA response letter to MedImmune positive sign.(MedImmune Inc.'s FluMi...
February 03, 2003
|
